USPTO trademark

ZORYVE

Opposition periodUSPTOWord and designClass 5

"ZORYVE" is a word and design mark owned by Arcutis Biotherapeutics, Inc., filed at the USPTO on July 24, 2026. It is in its opposition period and covers class 5 (Pharmaceuticals).

Official USPTO record
ZORYVE trademark as filed
As filed with the USPTO
Status
Opposition period
Since October 6, 2026
Filed
July 24, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50012275
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
1 class
Ownership

Who owns ZORYVE

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services ZORYVE is filed for, grouped by Nice class.

  • Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment of dermatological conditions, diseases and disorders

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Official gazette publication confirmation e-mailed
  2. Published for opposition
  3. Notification of notice of publication e-mailed
  4. Approved for pub - principal register
  5. Assigned to examiner
  6. Notice of design search code e-mailed
  7. New application office supplied data entered
  8. Application filing receipt mailed
  9. New application entered
FAQ

About ZORYVE

Who owns the trademark "ZORYVE"?

The USPTO trademark "ZORYVE" (application 50012275) is owned by Arcutis Biotherapeutics, Inc.

What is the status of "ZORYVE"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ZORYVE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019f9960-00e9-721a-83e3-14556ab69a63
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019f9960-00e9-721a-83e3-14556ab69a63",
  "object": "trademark",
  "mark_text": "ZORYVE",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "50012275",
  "filing_date": "2026-07-24",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Arcutis Biotherapeutics, Inc.",
      "entity_id": "ent_019ebbd1-0fa0-7102-b216-80df4ddf18e4"
    }
  ]
}